Mango polyphenolics reduce inflammation in intestinal colitis—involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo

Molecular Carcinogenesis

Volumn 56, Issue 1, 2017, Pages 197-207

  Kim, Hyemee ^a   Banerjee, Nivedita ^a   Barnes, Ryan C ^a   Pfent, Catherine M ^b   Talcott, Stephen T ^a   Dashwood, Roderick H ^a,c,d   Mertens Talcott, Susanne U ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

colitis; mango; miR 126; mTOR; rat

Indexed keywords

ANTAGOMIR; DEXTRAN SULFATE; GALLIC ACID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; MAMMALIAN TARGET OF RAPAMYCIN; MANGO EXTRACT; MICRORNA 126; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; S6 KINASE; TANNIN DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; MICRORNA; MIRN126 MICRORNA, HUMAN; POLYPHENOL; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEVERAGE; COLITIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LABELING INDEX; MANGO; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANALYSIS; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; FRUIT AND VEGETABLE JUICE; IMMUNOLOGY; INTESTINE; MALE; MANGIFERA; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; COLITIS; FRUIT AND VEGETABLE JUICES; HUMANS; INTESTINES; MALE; MANGIFERA; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; POLYPHENOLS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84963877854     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22484     Document Type: Article

References (55)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010; 28:573–621.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427–434.
3. Terzic J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010; 138:2101–2114 e2105.
4. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287:G7–17.
5. Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes, causes, and management strategies. World J Gastroenterol 2008; 14:3937–3947.
6. Munkholm P. Review article: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18:1–5.
7. Wang D, DuBois RN. The role of anti-inflammatory drugs in colorectal cancer. Ann Rev Med 2013; 64:131–144.
8. Yuan G, Wahlqvist ML, He G, Yang M, Li D. Natural products and anti-inflammatory activity. Asia Pac J Clin Nutr 2006; 15:143–152.
9. Shapiro H, Singer P, Halpern Z, Bruck R. Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis. Gut 2007; 56:426–435.
10. Masibo M, He Q. Major mango polyphenols and their potential significance to human health. Compr Rev Food Sci F 2008; 7:309–319.
11. Kim SH, Jun CD, Suk K, et al. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 2006; 91:123–131.
12. Erdelyi K, Kiss A, Bakondi E, et al. Gallotannin inhibits the expression of chemokines and inflammatory cytokines in A549 cells. Mol Pharmacol 2005; 68:895–904.
13. Noratto GD, Bertoldi MC, Krenek K, Talcott ST, Stringheta PC, Mertens-Talcott SU. Anticarcinogenic effects of polyphenolics from mango (Mangifera indica) varieties. J Agric Food Chem 2010; 58:4104–4112.
14. Giftson JS, Jayanthi S, Nalini N. Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 2010; 28:251–259.
15. Al-Halabi R, Bou Chedid M, Abou Merhi R, et al. Gallotannin inhibits NFkB signaling and growth of human colon cancer xenografts. Cancer Biol Ther 2011; 12:59–68.
16. Martinez G, Delgado R, Perez G, Garrido G, Nunez Selles AJ, Leon OS. Evaluation of the in vitro antioxidant activity of Mangifera indica L. extract (Vimang). Phytother Res 2000; 14:424–427.
17. Garrido G, Gonzalez D, Lemus Y, et al. In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG). Pharmacol Res 2004; 50:143–149.
18. Marquez L, Perez-Nievas BG, Garate I, et al. Anti-inflammatory effects of Mangifera indica L. extract in a model of colitis. World J Gastroenterol 2010; 16:4922–4931.
19. Zhang YJ, Dai Q, Sun DF, et al. MTOR signaling pathway is a target for the treatment of colorectal cancer. Ann Surg Oncol 2009; 16:2617–2628.
20. Sun X, Threadgill D, Jobin C. Campylobacter jejuni induces colitis through activation of mammalian target of rapamycin signaling. Gastroenterology 2012; 142:86–95 e85.
21. Bhonde MR, Gupte RD, Dadarkar SD, et al. A novel mTOR inhibitor is efficacious in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2008; 295:G1237–G1245.
22. Deore V, Yewalkar N, Bhatia D, et al. Synthesis and therapeutic evaluation of pyridyl based novel mTOR inhibitors. Bioorg Med Chem Lett 2009; 19:2949–2952.
23. Farkas S, Hornung M, Sattler C, et al. Rapamycin decreases leukocyte migration in vivo and effectively reduces experimentally induced chronic colitis. Int J Colorectal Dis 2006; 21:747–753.
24. Guo C, Sah FJ BL, Willson JKV, Markowitz SD, Guda K. The non-coding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008; 47:939–946.
25. Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem Pharmacol 2010; 80:1771–1792.
26. Alqurashi N, Hashimi SM, Wei MQ. Chemical inhibitors and microRNAs (miRNA) targeting the mammalian target of rapamycin (mTOR) pathway: Potential for novel anticancer therapeutics. Int J Mol Sci 2013; 14:3874–3900.
27. Guo C, Sah JF, Beard L, Willson JK, Markowitz SD, Guda K. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes Chromosomes Cancer 2008; 47:939–946.
28. Meister J, Schmidt MH. MiR-126 and miR-126*: New players in cancer. ScientificWorldJournal 2010; 10:2090–2100.
29. Krenek KA, Barnes RC, Talcott ST. Phytochemical composition and effects of commercial enzymes on the hydrolysis of gallic acid glycosides in mango (Mangifera indica L. cv.‘Keitt’) Pulp. J Agri Food Chem 2014; 62:9515–9521.
30. Masibo M, He Q. Mango bioactive compounds and related nutraceutical properties—A review. Food Rev Int 2009; 25:346–370.
31. Banerjee N, Kim H, Talcott S, Mertens-Talcott S. Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci (ACF) and Inflammation: Possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis 2013.
32. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models. Carcinogenesis 2003; 24:353–362.
33. Solomon L, Mansor S, Mallon P, et al. The dextran sulphate sodium (DSS) model of colitis: An overview. Comp Clin Pathol 2010; 19:235–239.
34. Hong MY, Bancroft LK, Turner ND, et al. Fish oil decreases oxidative DNA damage by enhancing apoptosis in rat colon. Nutr Cancer 2005; 52:166–175.
35. Banerjee N, Talcott S, Safe S, Mertens-Talcott SU. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: Potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res Treat 2012; 136:21–34.
36. Mertens-Talcott SU, Noratto GD, Li X, Angel-Morales G, Bertoldi MC, Safe S. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: Role of Sp transcription factors and microRNA-27a:ZBTB10. Mol Carcinog 2013; 52:591–602.
37. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008; 22:659–661.
38. Cui X, Jin Y, Hofseth AB, et al. Resveratrol suppresses colitis and colon cancer associated with colitis. Cancer Prev Res (Phila) 2010; 3:549–559.
39. Gaudio E, Taddei G, Vetuschi A, et al. Dextran sulfate sodium (DSS) colitis in rats: Clinical, structural, and ultrastructural aspects. Dig Dis Sci 1999; 44:1458–1475.
40. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694–702.
41. Rocha Ribeiro SM, Queiroz JH, Lopes Ribeiro de Queiroz ME, Campos FM, Pinheiro Sant'ana HM. Antioxidant in mango (Mangifera indica L.) pulp. Plant Foods Hum Nutr 2007; 62:13–17.
42. Dos Santos S, Delattre AI, De Longueville F, Bult H, Raes M. Gene expression profiling of LPS-stimulated murine macrophages and role of the NF-kappaB and PI3K/mTOR signaling pathways. Ann N Y Acad Sci 2007; 1096:70–77.
43. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2002; 47:1447–1457.
44. Kukitsu T, Takayama T, Miyanishi K, et al. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 2008; 14:48–54.
45. Schottelius AJ, Baldwin AS, Jr. A role for transcription factor NF-kappa B in intestinal inflammation. Int J Colorectal Dis 1999; 14:18–28.
46. Singer II, Kawka DW, Schloemann S, Tessner T, Riehl T, Stenson WF. Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 1998; 115:297–306.
47. Ho HH, Chang CS, Ho WC, Liao SY, Wu CH, Wang CJ. Anti-metastasis effects of gallic acid on gastric cancer cells involves inhibition of NF-kappaB activity and downregulation of PI3 K/AKT/small GTPase signals. Food Chem Toxicol 2010; 48:2508–2516.
48. Liu K-C, Huang A-C, Wu P-P, et al. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and-9 signaling pathways. Oncol Rep 2011; 26:177.
49. Frede S, Berchner-Pfannschmidt U, Fandrey J. Regulation of hypoxia-inducible factors during inflammation. Methods Enzymol 2007; 435:405–419.
50. Shah YM, Ito S, Morimura K, et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 2008; 134:2036–2048, 2048 e2031–2033.
51. Johnson SM, Gulhati P, Arrieta I, et al. Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res 2009; 29:3185–3190.
52. Angel-Morales G, Noratto G, Mertens-Talcott S. Red wine polyphenolics reduce the expression of inflammation markers in human colon-derived CCD-18Co myofibroblast cells: Potential role of microRNA-126. Food Funct 2012; 3:745–752.
53. Kim S-H, Jun C-D, Suk K, et al. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci 2006; 91:123–131.
54. Sharman MJ, Volek JS. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men. Clin Sci (Lond) 2004; 107:365–370.
55. Prasad S, Kalra N, Shukla Y. Induction of apoptosis by lupeol and mango extract in mouse prostate and LNCaP cells. Nutr Cancer 2007; 60:120–130.